Feigen M - Search Results

1

Low dose postoperative adjuvant radiation therapy for rectal cancer is ineffective.

Feigen M, Cummings B, Hawkins N, Keane T, O'Sullivan B, Wong S. Feigen M, et al. Radiother Oncol. 1988 Nov;13(3):181-6. doi: 10.1016/0167-8140(88)90054-0. Radiother Oncol. 1988. PMID: 3222463

2

The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer.

Mak D, Joon DL, Chao M, Wada M, Joon ML, See A, Feigen M, Jenkins P, Mercuri A, McNamara J, Poon A, Khoo V. Mak D, et al. Among authors: feigen m. Radiother Oncol. 2010 Nov;97(2):205-11. doi: 10.1016/j.radonc.2010.05.016. Epub 2010 Jul 1. Radiother Oncol. 2010. PMID: 20598390

3

Assessing the impact of FDG-PET in the management of anal cancer.

Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, Joon ML, See A, Feigen M, Rykers K, Kai C, Zupan E, Scott A. Nguyen BT, et al. Among authors: feigen m. Radiother Oncol. 2008 Jun;87(3):376-82. doi: 10.1016/j.radonc.2008.04.003. Epub 2008 Apr 29. Radiother Oncol. 2008. PMID: 18453023

4

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.

King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH; BIG 3-07/TROG 07.01 trial investigators. King MT, et al. Lancet Oncol. 2020 May;21(5):685-698. doi: 10.1016/S1470-2045(20)30085-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203696 Clinical Trial.

5

Leiomyosarcoma of the rectum: what role does adjuvant therapy play?

Kiffer JD, Castles L, Quong GG, Feigen M. Kiffer JD, et al. Among authors: feigen m. Australas Radiol. 1999 May;43(2):262-5. doi: 10.1046/j.1440-1673.1999.00646.x. Australas Radiol. 1999. PMID: 10901915

6

Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.

Feigen M, Lee ST, Lawford C, Churcher K, Zupan E, Scott AM, Hamilton C. Feigen M, et al. J Med Imaging Radiat Oncol. 2011 Jun;55(3):320-32. doi: 10.1111/j.1754-9485.2011.02274.x. J Med Imaging Radiat Oncol. 2011. PMID: 21696568

7

Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.

Lee ST, Ghanem M, Herbertson RA, Berlangieri SU, Byrne AJ, Tabone K, Mitchell P, Knight SR, Feigen M, Scott AM. Lee ST, et al. Among authors: feigen m. Mol Imaging Biol. 2009 Nov-Dec;11(6):473-9. doi: 10.1007/s11307-009-0203-6. Epub 2009 Mar 28. Mol Imaging Biol. 2009. PMID: 19330385

8

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.

Kiffer JD, Berlangieri SU, Scott AM, Quong G, Feigen M, Schumer W, Clarke CP, Knight SR, Daniel FJ. Kiffer JD, et al. Among authors: feigen m. Lung Cancer. 1998 Mar;19(3):167-77. doi: 10.1016/s0169-5002(97)00086-x. Lung Cancer. 1998. PMID: 9631364 Clinical Trial.

9

Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.

Hannah A, Feigen M, Quong G, Akhurst T, Berlangieri SU, Zimet A, Zalcberg J, McKay WJ, Scott AM. Hannah A, et al. Among authors: feigen m. Otolaryngol Head Neck Surg. 2000 Feb;122(2):304-6. doi: 10.1016/S0194-5998(00)70261-0. Otolaryngol Head Neck Surg. 2000. PMID: 10652412 No abstract available.

10

Incompletely excised basal cell carcinomas of the skin.

Kiffer JD, Wada M, Quong G, Feigen M. Kiffer JD, et al. Among authors: feigen m. Med J Aust. 1997 Nov 17;167(10):556-7. doi: 10.5694/j.1326-5377.1997.tb138886.x. Med J Aust. 1997. PMID: 9397048 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters